These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 10959748)

  • 1. Immunogenicity of acellular pertussis vaccines using two vaccines for primary immunization.
    von König CH; Herden P; Palitzsch D; Schneeweiss B; Bier N
    Pediatr Infect Dis J; 2000 Aug; 19(8):757-9. PubMed ID: 10959748
    [No Abstract]   [Full Text] [Related]  

  • 2. Do we need a new vaccine to control the re-emergence of pertussis?
    Mills KH; Ross PJ; Allen AC; Wilk MM
    Trends Microbiol; 2014 Feb; 22(2):49-52. PubMed ID: 24485284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modelling anti-pertussis toxin IgG antibody decay following primary and preschool vaccination with an acellular pertussis vaccine in UK subjects using a modified oral fluid assay.
    Fry NK; Litt DJ; Duncan J; Vaghji L; Warrener L; Samuel D; Andrews N; Harnden A; Harrison TG
    J Med Microbiol; 2013 Sep; 62(Pt 9):1281-1289. PubMed ID: 23722435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of duration of the intervals between immunization with DPT vaccine on the serological indices in children].
    Baeva EA; Selezneva TS; Glinskaia EV; Auzinia AV; Rudakova ZA
    Zh Mikrobiol Epidemiol Immunobiol; 1982 Feb; (2):90-6. PubMed ID: 6283770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pertussis vaccines: acellular versus whole cell. Perhaps a return to the past?].
    Cofré J
    Rev Chilena Infectol; 2015 Oct; 32(5):559-63. PubMed ID: 26633113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sustained efficacy during the first 6 years of life of 3-component acellular pertussis vaccines administered in infancy: the Italian experience.
    Salmaso S; Mastrantonio P; Tozzi AE; Stefanelli P; Anemona A; Ciofi degli Atti ML; Giammanco A;
    Pediatrics; 2001 Nov; 108(5):E81. PubMed ID: 11694665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pertussis: Where did we go wrong and what can we do about it?
    Locht C
    J Infect; 2016 Jul; 72 Suppl():S34-40. PubMed ID: 27161992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Immunogenicity and reactogenicity of acellular pertussis vaccines intended for adolescent and adults].
    Zawadka M; Lutyńska A
    Przegl Epidemiol; 2012; 66(1):99-105. PubMed ID: 22708307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Formation of whooping cough antibodies and immunoglobulins in children during immunization with combined pertussis-diphtheria-tetanus vaccine].
    Sokolovskaia AD; Zakharova MS; Shavrova EN; Shepsoval EIu; Usviat AZ
    Zh Mikrobiol Epidemiol Immunobiol; 1978 Jan; (1):88-91. PubMed ID: 204136
    [No Abstract]   [Full Text] [Related]  

  • 10. [Prophylaxis of pertussis: development and use of acellular pertussis vaccine].
    Chuprinina RP; Alekseeva IA; Ozeretskovskiĭ NA
    Zh Mikrobiol Epidemiol Immunobiol; 2006; (1):99-105. PubMed ID: 16532655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteomics of Bordetella pertussis whole-cell and acellular vaccines.
    Möller J; Kraner ME; Burkovski A
    BMC Res Notes; 2019 Jun; 12(1):329. PubMed ID: 31182148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibody responses and persistence in the two years after immunization with two acellular vaccines and one whole-cell vaccine against pertussis.
    Giuliano M; Mastrantonio P; Giammanco A; Piscitelli A; Salmaso S; Wassilak SG
    J Pediatr; 1998 Jun; 132(6):983-8. PubMed ID: 9627590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acellular pertussis vaccine as a booster dose for seventeen- to nineteen-month-old children immunized with either whole cell or acellular pertussis vaccine at two, four and six months of age.
    Halperin SA; Mills E; Barreto L; Pim C; Eastwood BJ
    Pediatr Infect Dis J; 1995 Sep; 14(9):792-7. PubMed ID: 8559630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of injection site on reactogenicity and immunogenicity of acellular and whole-cell pertussis component diphtheria-tetanus-pertussis vaccines in infants.
    Tapiainen T; Cherry JD; Heininger U
    Vaccine; 2005 Oct; 23(43):5106-12. PubMed ID: 16023771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Shift in the epidemiology of pertussis infection: an indication for pertussis vaccine boosters for adults?
    Yeh SH; Mink CM
    Drugs; 2006; 66(6):731-41. PubMed ID: 16706548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Acellular pertussis vaccine].
    Zakharova NS; Britsina MV; Mertsalova NU; Bazhanova IG; Ozeretskovskaia MN; Zaĭtsev EM; Poddubikov AV; Semenov BF
    Zh Mikrobiol Epidemiol Immunobiol; 2008; (1):35-41. PubMed ID: 18368750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Live attenuated B. pertussis as a single-dose nasal vaccine against whooping cough.
    Mielcarek N; Debrie AS; Raze D; Bertout J; Rouanet C; Younes AB; Creusy C; Engle J; Goldman WE; Locht C
    PLoS Pathog; 2006 Jul; 2(7):e65. PubMed ID: 16839199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and effectiveness of acellular pertussis vaccines: a 20-year Swedish experience.
    Hallander HO; Gustafsson L
    Expert Rev Vaccines; 2009 Oct; 8(10):1303-7. PubMed ID: 19803750
    [No Abstract]   [Full Text] [Related]  

  • 19. The control of pertussis--2007 and beyond.
    Halperin SA
    N Engl J Med; 2007 Jan; 356(2):110-3. PubMed ID: 17215528
    [No Abstract]   [Full Text] [Related]  

  • 20. [Pertussis vaccine for adolescents and adults].
    Perret P C
    Rev Chilena Infectol; 2006 Sep; 23(3):257-60. PubMed ID: 16896501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.